COVID-19 and supra-aortic trunks disease: review of literature about critical phase and sequelae

J Cardiovasc Surg (Torino). 2021 Sep 28. doi: 10.23736/S0021-9509.21.12021-X. Online ahead of print.ABSTRACTThe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 disease, a global pandemic. A strong association has been documented between COVID-19 and cardiovascular events, although the exact pathophysiological mechanism is still unclear. Carotid atherothrombosis and ischemic stroke represents one of the possible severe manifestations of COVID-19, as a leading cause of long-term disability and death. Different complex intertwined mechanisms seem to underlie the endothelitis which is the cause of multiple cardiovascular manifestations. To date, few case series describing COVID-19 and acute ischemic stroke caused by cervical carotid thrombosis have been published. All the patients shared common similar radiographic features, comorbidities, and biomarker profiles. The aim of this brief review is to analyze the impact of COVID-19 pandemic in the management of a Vascular Surgery Department, changing the daily vascular practice, as well as to provide practical suggestions for symptomatic carotid stenosis, while reviewing published literature.PMID:34581553 | DOI:10.23736/S0021-9509.21.12021-X
Source: The Journal of Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research

Related Links:

Hello! It's been awhile since I've been on here. I'm actually wrapping up a study abroad semester in Denmark, and I've had the absolute time of my life. It's been life changing and has definitely helped me confirm every reason for why I want to go to medical school. Definitely exactly what I needed after the pandemic! I'll be taking a gap year before med school and will apply my senior year. Anyways, now that I'm slowly coming back to reality and preparing for next semester, I'm feeling a... Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pre-Medical (MD) Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Prof Dame Sarah Gilbert says this will not be the last time a virus threatens our lives and our livelihoodsCoronavirus – latest updatesSee all our coronavirus coverageThe coronavirus pandemic that has so far killed more than 5 million people worldwide is far from over and the next one could be even more lethal, the creator of the Oxford/AstraZeneca vaccine has said.As fears grow over the threat posed by the highly mutated Omicron variant, detected in more than 30 countries,Prof Dame Sarah Gilbert cautioned that while it was increasingly obvious that “this pandemic is not done with us”, the next one could ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus UK news World news Science Infectious diseases Source Type: news
An Italian healthcare worker was caught trying to fraudulently receive a Covid-19 vaccine in a silicone arm.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Source Type: news
A small study in Boston looked at mixing and matching with the third shot.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Johnson & Pfizer Inc BioNTech SE Source Type: news
For the first time in two months, the US is averaging more than 100,000 new Covid-19 cases each day, shortly after millions of Americans traveled for the Thanksgiving holiday.
Source: Reuters: Health - Category: Consumer Health News Source Type: news
The Omicron variant of the coronavirus has spread to about one-third of U.S. states, but the Delta version remains the majority of COVID-19 infections as cases rise nationwide, U.S. health... #healthofficials
Source: Reuters: Health - Category: Consumer Health News Source Type: news
NEW BRUNSWICK, N.J., DECEMBER 5, 2021 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced preliminary results from an independent study, including a subset of participants from the Janssen-sponsored COV2008 study, conducted by Dan Barouch, M.D., Ph.D., et al. of Beth Israel Deaconess Medical Center (BIDMC), which showed that a booster shot of the Johnson &Johnson COVID-19 vaccine (Ad26.COV2.S), administered at six months after a two-dose primary regimen of BNT162b2, increased both antibody and T-cell responses. These results demonstrate the potential benefits of heterologous boosting (mix-and-match)....
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Coronavirus | COVID-19 | Disability | Heart | Ischemic Stroke | Pandemics | Radiography | Respiratory Medicine | SARS | Stroke | Thrombosis